Michael Sulu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael Sulu has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Alexander J H Fedorec
Department of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom
3 shared publications - Chris Barnes
University College London
3 shared publications - Mariana Petronela Hanga
Department of Biochemical Engineering, The Advanced Centre for Biochemical Engineering University College London London UK
3 shared publications - William Gordon
Department of Biochemical Engineering, The Advanced Centre for Biochemical Engineering University College London London UK
3 shared publications - Behzad D. Karkaria
Department of Cell & Developmental Biology, University College London, London, WC1E 6BT, UK
2 shared publications - Gary J. Lye
Department of Biochemical Engineering, The Advanced Centre for Biochemical Engineering University College London London UK
2 shared publications
Latest Publications
- Open Access
- 6 September 2026
- Published by Wiley in Food Bioengineering
- Vol. 5 (3) , 389-404
Under‐Explored Species, Breeds and Cell Types With Potential for Cultivated Meat Production
To achieve scale and cost parity, cultivated meat production must overcome critical bottlenecks such as the quality of starting cells. This review presents a systematic evaluation of unconventional and non‐traditional sources of cells as targeted strategies to address these specific manufacturing challenges. By moving beyond traditional domesticated livestock as sources for starting cells, this review highlights how under‐explored species or breeds offer distinct biological advantages with potential to directly improve bioprocess efficiency by leveraging natural traits such as enhanced proliferation rates, potential for spontaneous immortalisation and optimised differentiation. Furthermore, diversifying cell sourcing not only accelerates the path to commercial‐scale production but also enables the creation of novel cultivated meat products and other high‐value animal‐derived materials.
- 6 September 2026
- Published by Wiley in Food Bioengineering
- Vol. 5 (3) , 389-404
Open AccessUnder‐Explored Species, Breeds and Cell Types With Potential for Cultivated Meat Production
To achieve scale and cost parity, cultivated meat production must overcome critical bottlenecks such as the quality of starting cells. This review presents a systematic evaluation of unconventional and non‐traditional sources of cells as targeted strategies to address these specific manufacturing challenges. By moving beyond traditional domesticated livestock as sources for starting cells, this review highlights how under‐explored species or breeds offer distinct biological advantages with potential to directly improve bioprocess efficiency by leveraging natural traits such as enhanced proliferation rates, potential for spontaneous immortalisation and optimised differentiation. Furthermore, diversifying cell sourcing not only accelerates the path to commercial‐scale production but also enables the creation of novel cultivated meat products and other high‐value animal‐derived materials.
- Open Access
Serum-free media development and validation for cultivation of C2C12 immortalised murine myosatellite cell line for cultivated meat
The development of cost-effective, serum-free media is critical for scalable cultivated meat production. This study used high-throughput screening through a Design of Experiments (DoE) approach to develop an animal-free, serum-free medium (MMM1) specifically for the C2C12 murine myoblasts model cell line with applicability in cultivated meat research including for pet food. Low cost, food-grade inputs such as methylcellulose and spirulina extract resulted in significant cell growth improvements. The optimised MMM1 formulation containing low cost, food-grade inputs, achieved cumulative population doublings comparable to 10% (v/v) fetal bovine serum over four consecutive passages. Furthermore, MMM1 supported scalable cell expansion on commercially available dextran-based microcarriers (Cytodex-3) in both static and agitated conditions in spinner flasks, matching growth rates of serum-based controls. Finally, transitioning to a food-grade DMEM/F12 basal medium maintained cell proliferation equivalent to the pharmaceutical-grade DMEM/F12, but at a significantly lower cost, thus offering a viable strategy to substantially reduce biomanufacturing costs which is a critical challenge in cultivated meat production. Highlights: A serum-free medium formulation for C2C12 murine myoblasts (MMM1) C2C12 growth in MMM1 comparable to serum-based medium C2C12 growth in MMM1 in microcarrier culture as effective as serum-based medium MMM1 can be translated to be animal-free and fully food-grade Graphical
Open AccessSerum-free media development and validation for cultivation of C2C12 immortalised murine myosatellite cell line for cultivated meat
The development of cost-effective, serum-free media is critical for scalable cultivated meat production. This study used high-throughput screening through a Design of Experiments (DoE) approach to develop an animal-free, serum-free medium (MMM1) specifically for the C2C12 murine myoblasts model cell line with applicability in cultivated meat research including for pet food. Low cost, food-grade inputs such as methylcellulose and spirulina extract resulted in significant cell growth improvements. The optimised MMM1 formulation containing low cost, food-grade inputs, achieved cumulative population doublings comparable to 10% (v/v) fetal bovine serum over four consecutive passages. Furthermore, MMM1 supported scalable cell expansion on commercially available dextran-based microcarriers (Cytodex-3) in both static and agitated conditions in spinner flasks, matching growth rates of serum-based controls. Finally, transitioning to a food-grade DMEM/F12 basal medium maintained cell proliferation equivalent to the pharmaceutical-grade DMEM/F12, but at a significantly lower cost, thus offering a viable strategy to substantially reduce biomanufacturing costs which is a critical challenge in cultivated meat production. Highlights: A serum-free medium formulation for C2C12 murine myoblasts (MMM1) C2C12 growth in MMM1 comparable to serum-based medium C2C12 growth in MMM1 in microcarrier culture as effective as serum-based medium MMM1 can be translated to be animal-free and fully food-grade Graphical
- Open Access
Investigations into cyanobacteria, plant, and insect protein extracts as serum-replacement supplements for the expansion of cells for cultivated meat
Cultivated meat has undeniable potential to address some of the current detrimental impacts of animal farming, while addressing food security worldwide. However, one of the main challenges in cultivated meat production is manufacturing cost. The main contributor to cost is the culture media which comprises expensive components such as growth factors and animal-derived proteins. This study investigated alternative, food grade, high protein extracts as serum replacements in serum-free media formulations. The extracts were chosen to represent various sustainable sources of proteins: marine (spirulina e.g. cyanobacterium), plant (faba bean) and insect (mealworm flour). Different processing methods and different solvents were investigated for production of cell culture-compatible extracts which were then tested with mouse myoblasts (C2C12) and primary porcine myosatellites (pMyoSCs). A serum-free medium formulation containing 2.6% v/v spirulina extract was found to support long term growth of C2C12 cells for ∼10 population doublings compared to only ∼2 in the control. The processing steps were optimized, showing that a glycerine solution was best for free amino acid and protein yield (4950 µM total free amino acids, 11.45 mg/mL protein concentration). This solution had a positive effect on C2C12 cells, increasing their growth by up to 20% when added to the B8 medium. However, this benefit did not translate to pMyoSCs, which showed no significant growth increases in short-term screening. This work demonstrates a method for converting food grade protein powders into effective culture media supplements and highlights the potential of spirulina-based extracts for the use in cultivated meat. Abstract Figure: Graphical abstract Created in BioRender. Gordon-Petrovskii, W. (2025) https://BioRender.com/by7khs1
Open AccessInvestigations into cyanobacteria, plant, and insect protein extracts as serum-replacement supplements for the expansion of cells for cultivated meat
Cultivated meat has undeniable potential to address some of the current detrimental impacts of animal farming, while addressing food security worldwide. However, one of the main challenges in cultivated meat production is manufacturing cost. The main contributor to cost is the culture media which comprises expensive components such as growth factors and animal-derived proteins. This study investigated alternative, food grade, high protein extracts as serum replacements in serum-free media formulations. The extracts were chosen to represent various sustainable sources of proteins: marine (spirulina e.g. cyanobacterium), plant (faba bean) and insect (mealworm flour). Different processing methods and different solvents were investigated for production of cell culture-compatible extracts which were then tested with mouse myoblasts (C2C12) and primary porcine myosatellites (pMyoSCs). A serum-free medium formulation containing 2.6% v/v spirulina extract was found to support long term growth of C2C12 cells for ∼10 population doublings compared to only ∼2 in the control. The processing steps were optimized, showing that a glycerine solution was best for free amino acid and protein yield (4950 µM total free amino acids, 11.45 mg/mL protein concentration). This solution had a positive effect on C2C12 cells, increasing their growth by up to 20% when added to the B8 medium. However, this benefit did not translate to pMyoSCs, which showed no significant growth increases in short-term screening. This work demonstrates a method for converting food grade protein powders into effective culture media supplements and highlights the potential of spirulina-based extracts for the use in cultivated meat. Abstract Figure: Graphical abstract Created in BioRender. Gordon-Petrovskii, W. (2025) https://BioRender.com/by7khs1
- 29 November 2024
- Published by Springer Nature
- p. 127-138
Metaverse and the Future of Work—A Higher Education Perspective
- 29 November 2024
- Published by Springer Nature
- p. 127-138
Metaverse and the Future of Work—A Higher Education Perspective
- Open Access
- 28 October 2024
- Published by Elsevier in Bioresource Technology Reports
- Vol. 28
Techno-economic feasibility study of macroalgae for anaerobic digestion
- 28 October 2024
- Published by Elsevier in Bioresource Technology Reports
- Vol. 28
Open AccessTechno-economic feasibility study of macroalgae for anaerobic digestion
- Open Access
The Development and Characterisation of a P(3HB-co-4HB)–Bioactive Glass–Graphene Hydrogel as a Potential Formulation for Biomedical and Therapeutical Translation
The clinical management of wounds is known to be a significant challenge: not only does the dressing need to ensure and provide the appropriate barrier and healing characteristics, but consideration of patient compliance concerning comfort, functionality, and practicality also needs to be included. The poly(3-hydroxybutyrate-co-4-hydroxubutyrate) (P(3HB-co-4HB)) copolymer, isolated from Cupriavidus malaysiensis USM1020 (C. malaysiensis USM1020), was produced in the presence of excess carbon sources (1,4-butanediol and 1,6-hexanediol) using either a shake flask cultivation process or a bioreactor fermentation system. P(3HB-co-4HB) is widely known to be biodegradable and highly biocompatible and contains a tuneable 4HB monomer molar fraction, which is known to affect the final physicochemical properties of the intracellular copolymer. In this paper, we describe not only the fabrication of the polymeric gel but also its optimised profiling using a range of physical and mechanical techniques, i.e., SEM, FTIR, DMA, DSC, and WCA. The further enhancement of the gel through additional functionalisation with sol-gel-derived bioactive glass and liquid-exfoliated graphene was also investigated. The biocompatibility and biological characterisation of the substrates was assessed using murine osteoblasts (MC3T3), human primary dermal fibroblasts (HDFs), human fibroblast (BJ) cells, and standard cell culture assays (i.e., metabolic activity, LDH release, and live/dead staining). In short, P(3HB-co-4HB) was successfully isolated from the bacteria, with the defined physico-chemical profiles dependent on the culture substrate and culturing platform used. The additional enhancement of the copolymer with bioactive glass and/or graphene was also demonstrated by varying the combination loading of the materials, i.e., graphene resulted in an increase in tensile strength (~11 MPa) and the wettability increased following the incorporation of bioactive glass and 0.01 wt% graphene (WCA ~46.3°). No detrimental effects in terms of biocompatibility were noticed during the 7 days of culture in the primary and established cell lines. This study demonstrates the importance of optimising each of the individual components within the biocomposite and their relationship concerning the fine-tuning of the material’s properties, thus targeting and impacting the endpoint application.
Open AccessThe Development and Characterisation of a P(3HB-co-4HB)–Bioactive Glass–Graphene Hydrogel as a Potential Formulation for Biomedical and Therapeutical Translation
The clinical management of wounds is known to be a significant challenge: not only does the dressing need to ensure and provide the appropriate barrier and healing characteristics, but consideration of patient compliance concerning comfort, functionality, and practicality also needs to be included. The poly(3-hydroxybutyrate-co-4-hydroxubutyrate) (P(3HB-co-4HB)) copolymer, isolated from Cupriavidus malaysiensis USM1020 (C. malaysiensis USM1020), was produced in the presence of excess carbon sources (1,4-butanediol and 1,6-hexanediol) using either a shake flask cultivation process or a bioreactor fermentation system. P(3HB-co-4HB) is widely known to be biodegradable and highly biocompatible and contains a tuneable 4HB monomer molar fraction, which is known to affect the final physicochemical properties of the intracellular copolymer. In this paper, we describe not only the fabrication of the polymeric gel but also its optimised profiling using a range of physical and mechanical techniques, i.e., SEM, FTIR, DMA, DSC, and WCA. The further enhancement of the gel through additional functionalisation with sol-gel-derived bioactive glass and liquid-exfoliated graphene was also investigated. The biocompatibility and biological characterisation of the substrates was assessed using murine osteoblasts (MC3T3), human primary dermal fibroblasts (HDFs), human fibroblast (BJ) cells, and standard cell culture assays (i.e., metabolic activity, LDH release, and live/dead staining). In short, P(3HB-co-4HB) was successfully isolated from the bacteria, with the defined physico-chemical profiles dependent on the culture substrate and culturing platform used. The additional enhancement of the copolymer with bioactive glass and/or graphene was also demonstrated by varying the combination loading of the materials, i.e., graphene resulted in an increase in tensile strength (~11 MPa) and the wettability increased following the incorporation of bioactive glass and 0.01 wt% graphene (WCA ~46.3°). No detrimental effects in terms of biocompatibility were noticed during the 7 days of culture in the primary and established cell lines. This study demonstrates the importance of optimising each of the individual components within the biocomposite and their relationship concerning the fine-tuning of the material’s properties, thus targeting and impacting the endpoint application.
- Open Access
- 22 December 2023
- Published by Qeios Ltd
Review of: "Techno-Economic Fermentative Microbe-Based Industrial Production of Lactic Acid (LA): Potential Future Prospects and Constraints"
This is a good paper but needs a few things for improvement. Title: this doesnt accurately describe the paper, so changing this would improve it. The contents of this are good, but this could benefit from restructuring. starting with the...
- 22 December 2023
- Published by Qeios Ltd
Open AccessReview of: "Techno-Economic Fermentative Microbe-Based Industrial Production of Lactic Acid (LA): Potential Future Prospects and Constraints"
This is a good paper but needs a few things for improvement. Title: this doesnt accurately describe the paper, so changing this would improve it. The contents of this are good, but this could benefit from restructuring. starting with the...
- Open Access
Optimisation of Ultrasound Pretreatment of Microalgal Biomass for Effective Biogas Production through Anaerobic Digestion Process
The anaerobic digestion, AD, process presents a solution for sustainable waste management, greenhouse gas mitigation and energy production for growing population needs and requirements. Adopting a biorefinery approach that utilises different feedstock may enhance energy production and support optimisation of the anaerobic digestion process. Algae is a promising feedstock that could be used for energy production via the anaerobic digestion process. Microalgal biomass is rich in carbohydrates and lipids; however, many species of algae exhibit tough cell walls that could also be difficult to digest and may influence or inhibit the efficiency of the AD process. This study concentrated on the comparison of AD remediation of two marine algal biomass species, Tetraselmis suecica and Nannochloropsis oceanica. The two species were pre-treated with an ultrasound technique and compared for their methane production using biochemical methane potential tests. For Tetraselmis, a specific methane production of 0.165 LCH4/KgVS was observed; however, for Nannochloropsis, a value of 0.101 LCH4/KgVS was observed for the samples treated with ultrasound. The BMP results from this study show that among the two micro-algae species tested, Tetraselmis suecica is found to be a better substrate for methane production potential. Contrary to increasing the specific methane production, ultrasound cavitation caused a slight decrease in the specific methane production values for both Nannochloropsis oceanica and Tetraselmis suecica biomass residues. The pre-treatment of the biomass using ultrasound techniques provided comparable results and can be recommended for effective bioenergy production. However, further research is required for the optimisation of the pre-treatment of microalgae and for the integration of microalgal biorefineries for circular economy.
Open AccessOptimisation of Ultrasound Pretreatment of Microalgal Biomass for Effective Biogas Production through Anaerobic Digestion Process
The anaerobic digestion, AD, process presents a solution for sustainable waste management, greenhouse gas mitigation and energy production for growing population needs and requirements. Adopting a biorefinery approach that utilises different feedstock may enhance energy production and support optimisation of the anaerobic digestion process. Algae is a promising feedstock that could be used for energy production via the anaerobic digestion process. Microalgal biomass is rich in carbohydrates and lipids; however, many species of algae exhibit tough cell walls that could also be difficult to digest and may influence or inhibit the efficiency of the AD process. This study concentrated on the comparison of AD remediation of two marine algal biomass species, Tetraselmis suecica and Nannochloropsis oceanica. The two species were pre-treated with an ultrasound technique and compared for their methane production using biochemical methane potential tests. For Tetraselmis, a specific methane production of 0.165 LCH4/KgVS was observed; however, for Nannochloropsis, a value of 0.101 LCH4/KgVS was observed for the samples treated with ultrasound. The BMP results from this study show that among the two micro-algae species tested, Tetraselmis suecica is found to be a better substrate for methane production potential. Contrary to increasing the specific methane production, ultrasound cavitation caused a slight decrease in the specific methane production values for both Nannochloropsis oceanica and Tetraselmis suecica biomass residues. The pre-treatment of the biomass using ultrasound techniques provided comparable results and can be recommended for effective bioenergy production. However, further research is required for the optimisation of the pre-treatment of microalgae and for the integration of microalgal biorefineries for circular economy.
- Open Access
- 30 March 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-12
Single strain control of microbial consortia
The scope of bioengineering is expanding from the creation of single strains to the design of microbial communities, allowing for division-of-labour, specialised sub-populations and interaction with “wild” microbiomes. However, in the absence of stabilising interactions, competition between microbes inevitably leads to the removal of less fit community members over time. Here, we leverage amensalism and competitive exclusion to stabilise a two-strain community by engineering a strain of Escherichia coli which secretes a toxin in response to competition. We show experimentally and mathematically that such a system can produce stable populations with a composition that is tunable by easily controllable parameters. This system creates a tunable, stable two-strain consortia while only requiring the engineering of a single strain.
- 30 March 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-12
Open AccessSingle strain control of microbial consortia
The scope of bioengineering is expanding from the creation of single strains to the design of microbial communities, allowing for division-of-labour, specialised sub-populations and interaction with “wild” microbiomes. However, in the absence of stabilising interactions, competition between microbes inevitably leads to the removal of less fit community members over time. Here, we leverage amensalism and competitive exclusion to stabilise a two-strain community by engineering a strain of Escherichia coli which secretes a toxin in response to competition. We show experimentally and mathematically that such a system can produce stable populations with a composition that is tunable by easily controllable parameters. This system creates a tunable, stable two-strain consortia while only requiring the engineering of a single strain.